FDAFDA · Food and drugs·Recall number D-0851-2021
Lyrica CR (pregabalin) extended release tablets, 330 mg, 30-count bottles, Rx only, Distributed by Parke-Davis Division of Pfizer Inc., NY, NY 10017, NDC 0071-1029-01
Published October 6, 2021 · Recall initiated: August 23, 2021
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- Viatris
- Distributor
- Nationwide within the United States
- Lot
- Lot #: DN5396, EP9726, EK2417, Exp. Date August 2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.